Psychiatry

A Specialized CRO Partner for Psychiatric Studies

Developing effective treatments for psychiatric disorders requires a CRO partner with the specialized expertise and capabilities to address the unique challenges involved with these programs. As a global CRO with a unique approach to clinical development, Medpace is well suited to manage some of the industry’s most complex and challenging trials.

Our medical, regulatory and operational experts provide strategic leadership throughout your program to streamline and accelerate product approval. Our Sponsors benefit from:

• A unique scientifically-driven approach to clinical development that puts our team of medical doctors at the center of your trials, providing strategic direction for study design and planning, training operational staff, working with primary investigators, providing medical monitoring, and meeting with regulatory agencies
• 5 Full-time, in-house neurologists experienced in designing and managing trials in psychiatry and neurology
• Experienced in key indications including substance use, depression, bipolar disorder, anxiety disorders, and schizophrenia
• A unique concentration of study experience in rare disease and orphan indications
• Our physicians and professional staff have in-depth knowledge of screening tools and rater scales and will provide oversight for rater services including subjective assessments, inter-rater reliability, and scale validation
• Broad experience conducting Phase I-IV clinical trials spanning adult and pediatric populations
• Long-term relationships with successful experienced sites, networks, and key opinion leaders (KOLs)
• Extensive early phase and transitional development expertise supported by Medpace’s Phase I Clinical Pharmacology Unit
• Integrated imaging and central laboratory services, ensuring seamless logistics, review and testing
• Global footprint with operations in North America, Latin America, Europe, Asia-Pacific and Africa